OTCMKTS:LXRPLexaria Bioscience Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Lexaria Bioscience Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.30 +0.01 (+2.88 %) (As of 04/9/2020 03:37 AM ET) Add Compare Share Today's Range$0.28Now: $0.30▼$0.3050-Day Range$0.28MA: $0.35▼$0.5052-Week Range$0.23Now: $0.30▼$1.34Volume161,794 shsAverage Volume112,771 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Lexaria Bioscience Corp. engages in the development of strategic partnerships and in the proprietary nutrient infusion technologies for the production of superfoods. It operates through the IP Licensing and Consumer Products segments. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Lexaria Bioscience. Previous Next 2.3 Community Rank Outperform VotesLexaria Bioscience has received 60 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLexaria Bioscience has received 68 “underperform” votes. (Add your “underperform” vote.)Community SentimentLexaria Bioscience has received 53.13% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Lexaria Bioscience and other stocks. Vote “Outperform” if you believe LXRP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LXRP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLexaria Bioscience does not currently pay a dividend.Dividend GrowthLexaria Bioscience does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Lexaria Bioscience insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Packaged Foods Sub-IndustryN/A SectorConsumer Defensive Current SymbolOTCMKTS:LXRP Previous Symbol CUSIP52886N208 CIK1348362 Webhttp://www.lexariaenergy.com/ Phone(250) 765-6424Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive LXRP News and Ratings via Email Sign-up to receive the latest news and ratings for LXRP and its competitors with MarketBeat's FREE daily newsletter. OTC:LXRP Rates by TradingView Lexaria Bioscience (OTCMKTS:LXRP) Frequently Asked Questions How has Lexaria Bioscience's stock been impacted by COVID-19 (Coronavirus)? Lexaria Bioscience's stock was trading at $0.3101 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LXRP shares have decreased by 3.3% and is now trading at $0.30. View which stocks have been most impacted by Coronavirus. Has Lexaria Bioscience been receiving favorable news coverage? News coverage about LXRP stock has trended very negative on Thursday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Lexaria Bioscience earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the oil and gas exploration company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutLexaria Bioscience. Who are some of Lexaria Bioscience's key competitors? Some companies that are related to Lexaria Bioscience include 1PM Industries (OPMZ), AMINCOR INC/SH CL A (AMNC), Apotheca Biosciences (PCFP), Bellamy's Australia (BAL), Capilano Honey (CZZ), Danone (BN), ForeverGreen Worldwide (FVRG), Glanbia (GLAPF), GRUMA (GPAGF), Grupo Bimbo (GRBMF), GRUPO BIMBO SAB/S (BMBOY), Grupo Lala SAB De CV (GRPBF), Jatenergy (JAT), Kerry Group (KRYAF) and Kewpie (KWPCY). What other stocks do shareholders of Lexaria Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACBFF), OrganiGram (OGI), CV Sciences (CVSI), Aphria (APHQF), InMed Pharmaceuticals (IMLFF), GW Pharmaceuticals PLC- (GWPH), Alibaba Group (BABA) and 22nd Century Group (XXII). Who are Lexaria Bioscience's key executives? Lexaria Bioscience's management team includes the following people: Christopher A. Bunka, Chairman & Chief Executive OfficerJohn Martin Docherty, President & DirectorAllan Spissinger, Chief Financial Officer, Secretary & TreasurerAlex Blanchard, Manager-Investor Relations & CommunicationsEd Ergenzinger, Chief Legal Officer & Senior VP-Innovation What is Lexaria Bioscience's stock symbol? Lexaria Bioscience trades on the OTCMKTS under the ticker symbol "LXRP." How do I buy shares of Lexaria Bioscience? Shares of LXRP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Lexaria Bioscience's stock price today? One share of LXRP stock can currently be purchased for approximately $0.30. What is Lexaria Bioscience's official website? The official website for Lexaria Bioscience is http://www.lexariaenergy.com/. How can I contact Lexaria Bioscience? Lexaria Bioscience's mailing address is 156 Valleyview Rd, KELOWNA, BC V1X 3M4, Canada. The oil and gas exploration company can be reached via phone at (250) 765-6424. This page was last updated on 4/9/2020 by MarketBeat.com StaffFeatured Article: How Short Selling Works
